Table 2.
Screening of 601 compounds of MMV Pathogen Box and Pandemic Response Box against PDR K. pneumoniae.
| Compounds | Triplicates |
Avg OD | % IG | Pf(CFU/ml) | MIC (μM) | ||
|---|---|---|---|---|---|---|---|
| OD1 | OD2 | OD3 | |||||
| MMV1580854 | 0.082 | 0.081 | 0.067 | 0.076 | 94.60 | 1.3 × 106 | ≥2 |
| MMV1579788 | 0.073 | 0.063 | 0.093 | 0.076 | 94.65 | 9.4 × 106 | ≥5 |
| Eravacycline | 0.095 | 0.081 | 0.084 | 0.086 | 93.13 | 2.8 × 107 | ≥2 |
| Epetraborole | 0.078 | 0.091 | 0.047 | 0.072 | 95.29 | 8.2 × 104 | ≥2 |
| MMV1578564 | 0.09 | 0.057 | 0.048 | 0.065 | 96.32 | 9.0 × 105 | ≥2 |
Inhibition of the compounds is represented as %IG (Percentage of growth inhibition) based on the optical density (OD) at 600 nm. The persister subpopulation is denoted as PF(Persister frequency)in the table as CFU/ml units. Minimum Inhibitory Concentration (MIC) at which the compounds completely inhibit growth at a given concentration (μM) is represented.MMV ID for drugs: Eravacycline-MMV1578574, Epetraborole - MMV1578566.